CB Therapeutics

CB Therapeutics is an innovative producer of high value molecules, compounds and rare ingredients from simple feedstock utilizing many different types of hosts and systems, including yeast, bacteria and cell-free expression systems. CB Therapeutics expertise in synthetic genomics, bio-engineering and cellular production processes can produce a broad range of phytochemicals faster, more sustainably, at greater yields and with higher purity, consistency and efficiency than competitive platforms. CB Therapeutics is focused on the discovery, research, development and production of tryptamines, cannabinoids and other molecules and compounds to advance Neuroscience and bring therapeutics to market to solve mankinds most challenging mental healthcare...

Biotechnology,r&d,cellular agriculture,cannabinoids,tryptamines,synthetic biology,neuroscience,addiction,ptsd,depression,mental health,and mental healthcare

Cb therapeutics operates in the Biotechnology industry.

Cb therapeutics's revenue is 11m - 100m

Cb therapeutics has 11 - 50 employees.